PRIMARY HYPEROXALURIA TYPE 1

Clinical trials for PRIMARY HYPEROXALURIA TYPE 1 explained in plain language.

Never miss a new study

Get alerted when new PRIMARY HYPEROXALURIA TYPE 1 trials appear

Sign up with your email to follow new studies for PRIMARY HYPEROXALURIA TYPE 1, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1 Not yet recruiting 1 Not yet finished but already full! 1 Completed 1

New hope for rare kidney disease: drug trial targets severe cases

Disease control Recruiting now

This study tests an experimental drug called DCR-PHXC in people with primary hyperoxaluria type 1 (PH1) who have severe kidney damage, whether or not they are on dialysis. The goal is to see if the drug can safely lower oxalate levels in the blood, which may help control the dise…

Matched conditions: PRIMARY HYPEROXALURIA TYPE 1

Phase: PHASE2 • Sponsor: Dicerna Pharmaceuticals, Inc., a Novo Nordisk company • Aim: Disease control

Last updated May 17, 2026 17:07 UTC

PRIMARY HYPEROXALURIA TYPE 1

Get alerted when new PRIMARY HYPEROXALURIA TYPE 1 trials appear

New hope for rare kidney disease: drug trial targets severe cases